These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33768360)

  • 1. A Data-Mining Approach for the Quantitative Assessment of Physicochemical Properties of Molecular Compounds in the Skin Flux.
    Choi HK; Acharya G; Lee Y; Lee CH
    AAPS PharmSciTech; 2021 Mar; 22(3):117. PubMed ID: 33768360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
    Funke AP; Günther C; Müller RH; Lipp R
    Drug Dev Ind Pharm; 2003 Aug; 29(7):785-93. PubMed ID: 12906336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.
    Wasdo SC; Sloan KB
    Pharm Res; 2004 Jun; 21(6):940-6. PubMed ID: 15212157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin.
    Gwak HS; Oh IS; Chun IK
    Arch Pharm Res; 2003 Aug; 26(8):644-8. PubMed ID: 12967200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships.
    Cronin MT; Dearden JC; Moss GP; Murray-Dickson G
    Eur J Pharm Sci; 1999 Mar; 7(4):325-30. PubMed ID: 9971916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic flux profiles of melatonin: the Yin-Yang of transdermal permeation enhancement mediated by fatty alcohol enhancers.
    Kandimalla KK; Babu RJ; Singh M
    J Pharm Sci; 2010 Jan; 99(1):209-18. PubMed ID: 19530074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of chirality, physicochemical properties, and permeation enhancers on the transdermal permeation of amlodipine across rat skin.
    Zeng A; Wang C; Yuan B; Yang G; Fu Q
    Drug Dev Ind Pharm; 2010 Jun; 36(6):724-34. PubMed ID: 20136484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple rules defining the potential of compounds for transdermal delivery or toxicity.
    Magnusson BM; Pugh WJ; Roberts MS
    Pharm Res; 2004 Jun; 21(6):1047-54. PubMed ID: 15212171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Permeation Enhancement in Aqueous Solution: Correlation With Equilibrium Enhancer Concentration and Octanol/Water Partition Coefficient.
    Li SK; Chantasart D
    J Pharm Sci; 2019 Jan; 108(1):350-357. PubMed ID: 30165068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
    Cui H; Quan P; Zhou Z; Fang L
    Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation of flux through a silicone membrane with flux through hairless mouse skin and human skin in vitro.
    Wasdo SC; Juntunen J; Devarajan H; Sloan KB
    Int J Pharm; 2009 May; 373(1-2):62-7. PubMed ID: 19429289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin.
    Chatterjee DJ; Li WY; Koda RT
    Pharm Res; 1997 Aug; 14(8):1058-65. PubMed ID: 9279889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2000 Nov; 89(11):1415-31. PubMed ID: 11015687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.
    Cheong HA; Choi HK
    Pharm Res; 2002 Sep; 19(9):1375-80. PubMed ID: 12403076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The control of skin-permeating rate of bisoprolol by ion-pair strategy for long-acting transdermal patches.
    Song W; Cun D; Xi H; Fang L
    AAPS PharmSciTech; 2012 Sep; 13(3):811-5. PubMed ID: 22639239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
    Mutalik S; Parekh HS; Davies NM; Udupa N
    Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal penetration of cytarabine and its 5'-O alkyl ester derivatives.
    Legoabe LJ; Breytenbach JC; N'Da DD; Breytenbach JW
    Med Chem; 2010 Mar; 6(2):108-13. PubMed ID: 20218966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam.
    Ki HM; Choi HK
    Arch Pharm Res; 2007 Feb; 30(2):215-21. PubMed ID: 17366744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.